SCHEMBL25575775

SCHEMBL25575775

CCCCNC(=O)c1cc(-c2ccccc2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
RAB9A P51151 2/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
KMT2A Q03164 1/20 0.53
POLB P06746 1/20 0.52
KDM4E B2RXH2 2/20 0.50
HTT P42858 2/20 0.50
TSHR P16473 1/20 0.50
USP30 Q70CQ3 2/20 0.49
NAMPT P43490 1/20 0.48
GAA P10253 1/20 0.48
HIF1A Q16665 2/20 0.48
ALOX15 P16050 1/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
FAAH O00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25576017 0.96 NAAA (0.52) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL24620722 0.95 NAAA (0.55) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL19747788 0.87 MEN1 (0.53) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL17652562 0.86 HDAC1 (0.54) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL19747112 0.85 SMN1; SMN2 (0.52) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL17661235 0.85 HDAC1 (0.49) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL17874030 0.84 MAPT (0.56) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL17652621 0.84 SMN1; SMN2 (0.51) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL17652550 0.84 MEN1 (0.55) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL13901842 0.84 FAAH (0.61) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3472156-B1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS INC (US) 2023-06-07 EP disclosed